182 related articles for article (PubMed ID: 3011981)
1. Epstein-Barr virus serology in bone marrow transplantations: a one-year retrospective study with detection of EBV IgM-VCA-specific antibodies.
Morinet F; Icart J; Ruelle C; Gluckman E; Perol Y
J Med Virol; 1986 Apr; 18(4):349-60. PubMed ID: 3011981
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus VCA IgM and EBNA IgG antibodies titered by immunofluorescence in microplates. A semi-automated method based on microtiter system.
Lamy ME; Favart AM; Leclercq MF; Segas M; Mendez M; Lhoir C; Cornu C; Burtonboy G
Med Microbiol Immunol; 1982; 170(4):247-53. PubMed ID: 6285158
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
4. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
Linde A; Andersson J; Lundgren G; Wahren B
J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
[TBL] [Abstract][Full Text] [Related]
5. Contribution to rapid diagnosis of infectious mononucleosis.
Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
Corrales I; Giménez E; Navarro D
Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-related serology in marrow transplant recipients.
Lange B; Henle W; Meyers JD; Yang LC; August C; Koch P; Arbeter A; Henle G
Int J Cancer; 1980 Aug; 26(2):151-7. PubMed ID: 6259066
[TBL] [Abstract][Full Text] [Related]
9. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
[TBL] [Abstract][Full Text] [Related]
10. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
Andersson A; Vetter V; Kreutzer L; Bauer G
J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
de Ory F; Echevarría JM
Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
[TBL] [Abstract][Full Text] [Related]
12. The seroepidemiology of infection due to Epstein-Barr virus in southern India.
Venkitaraman AR; Lenoir GM; John TJ
J Med Virol; 1985 Jan; 15(1):11-6. PubMed ID: 2981976
[TBL] [Abstract][Full Text] [Related]
13. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
14. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
[TBL] [Abstract][Full Text] [Related]
16. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
Harada M; Sairenji T; Takaki K; Hinuma Y
Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
18. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.
Hyöty H; Räsänen L; Hiltunen M; Lehtinen M; Huupponen T; Leinikki P
APMIS; 1991 Apr; 99(4):359-63. PubMed ID: 1645169
[TBL] [Abstract][Full Text] [Related]
19. Immune status towards Epstein-Barr virus in a group of Sicilian children.
Ammatuna P; Di Stefano R; Arista S; Sammartano F; Bellia L; Formica P; Albeggiani A
Eur J Epidemiol; 1989 Jun; 5(2):219-23. PubMed ID: 2548891
[TBL] [Abstract][Full Text] [Related]
20. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
